Results 161 to 170 of about 2,212 (184)
Some of the next articles are maybe not open access.

Real-life experience with rilonacept for the treatment of recurrent pericarditis

European Heart Journal
Abstract Background Rilonacept, a soluble Interleukin-1 (IL-1) receptor fusion protein that neutralizes IL-1α and IL-1β, has shown efficacy in symptom resolution, weaning of standard-of-care therapies, and reducing the frequency of recurrent pericarditis (RP) episodes in clinical trials.
G Thomas   +3 more
openaire   +1 more source

Rilonacept: A Newly Approved Treatment for Recurrent Pericarditis

Annals of Pharmacotherapy, 2022
Nicholas C Schwier
exaly  

Use of rilonacept in patients with recurrent pericarditis during COVID-19 disease

Expert Opinion on Biological Therapy, 2022
Lucia, Trotta   +9 more
openaire   +2 more sources

The IL-1 Trap Rilonacept Resolves and Prevents Recurrent Pericarditis

Nature Reviews Cardiology, 2021
Irene Fernández-Ruiz
exaly  

Anakinra/Rilonacept

Reactions Weekly
openaire   +1 more source

Home - About - Disclaimer - Privacy